StreetAlpha
13F holdings · Q3 2026

Nan Fung Group Holdings

Kai Tak, K3 · files as Nan Fung Group Holdings Ltd
Know the moment Nan Fung Group Holdings filesYou follow Nan Fung Group Holdings An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1782539

Nan Fung Group Holdings reported 29 stocks worth $150M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LBRX (16.2%), MPLT (15.7%) and OBX (8.4%). Compared with Q2 2026, the fund opened new positions in OBX, NUVB and NAMS, added to MPLT and PCOR, trimmed RXRX and sold out of CHYM.

Latest filing: what Nan Fung Group Holdings did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
5 new2 added1 trimmed1 sold outBought about $43.6M · sold about $2.1M
New 5
Added 2
Trimmed 1
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$150M+13.8% vs last quarter
Stocks held295 new · 1 sold out
Top 5 weight56.3%fairly concentrated
Turnover31%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
LBRX
LB Pharmaceuticals Inc
$24.2M16.2%631KNo change5 of 8
2
MPLT
Maplight Therapeutics Inc
$23.4M15.7%2.3M+1.3M (+137%)4 of 8
3
OBX
Obsidian Therapeutics Inc
$12.6M8.4%919KNew position1 of 8
4
CYBIN INC
$12.1M8.1%987KNo change4 of 8
5
EVMN
Evommune Inc
$11.9M8.0%1.4MNo change4 of 8
6
NUVB
Nuvation Bio Inc
$7.4M5.0%1.3MNew position1 of 8
7
INCY
Incyte Corp
$6.5M4.4%54KNo change8 of 8
8
ONC
Beone Medicines Ltd
$5.8M3.8%16KNo change8 of 8
9
RYTM
Rhythm Pharmaceuticals Inc
$4.7M3.1%49KNo change8 of 8
10
PCOR
Procore Technologies Inc
$4.6M3.1%89K+36K (+67%)4 of 8
🔒 19 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CHYM
Chime Finl Inc
$432K21K

Reported value

last 8 quarters
$117MQ4 '24
$123MQ1 '25
$63.4MQ2 '25
$59.6MQ3 '25
$112MQ4 '25
$121MQ1 '26
$131MQ2 '26
$150MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Nan Fung Group Holdings 13F FAQ

What does Nan Fung Group Holdings own?

Nan Fung Group Holdings reported 29 stocks worth $150M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LBRX (16.2%), MPLT (15.7%) and OBX (8.4%). The table above lists every position in the filing (the top 10 without an account).

What did Nan Fung Group Holdings buy and sell in Q3 2026?

Compared with Q2 2026: 5 new positions, 2 added to, 1 trimmed and 1 sold out. New positions include OBX, NUVB and NAMS. It sold all of CHYM.

When will Nan Fung Group Holdings file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Nan Fung Group Holdings's portfolio worth?

The Q3 2026 filing reports $150M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.